Myriad Genetics, Inc. (MYGN)
4.31
+0.11
(+2.62%)
USD |
NASDAQ |
Oct 09, 16:00
4.315
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Market Cap : 412.04M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 412.04M |
| October 08, 2026 | 401.52M |
| October 07, 2026 | 409.17M |
| October 06, 2026 | 409.17M |
| October 05, 2026 | 437.85M |
| October 02, 2026 | 434.02M |
| October 01, 2026 | 388.14M |
| September 30, 2026 | 412.04M |
| September 29, 2026 | 404.39M |
| September 28, 2026 | 405.34M |
| September 25, 2026 | 398.65M |
| September 24, 2026 | 395.78M |
| September 23, 2026 | 383.36M |
| September 22, 2026 | 384.31M |
| September 21, 2026 | 383.36M |
| September 18, 2026 | 371.88M |
| September 17, 2026 | 395.78M |
| September 16, 2026 | 369.02M |
| September 15, 2026 | 370.93M |
| September 14, 2026 | 362.32M |
| September 11, 2026 | 326.95M |
| September 10, 2026 | 321.22M |
| September 09, 2026 | 304.96M |
| September 08, 2026 | 304.01M |
| September 04, 2026 | 304.96M |
| Date | Value |
|---|---|
| September 03, 2026 | 308.79M |
| September 02, 2026 | 308.79M |
| September 01, 2026 | 304.01M |
| August 31, 2026 | 307.83M |
| August 28, 2026 | 302.10M |
| August 27, 2026 | 304.01M |
| August 26, 2026 | 298.27M |
| August 25, 2026 | 304.96M |
| August 24, 2026 | 291.58M |
| August 21, 2026 | 305.92M |
| August 20, 2026 | 307.83M |
| August 19, 2026 | 304.96M |
| August 18, 2026 | 274.37M |
| August 17, 2026 | 291.58M |
| August 14, 2026 | 289.67M |
| August 13, 2026 | 303.05M |
| August 12, 2026 | 308.79M |
| August 11, 2026 | 307.83M |
| August 10, 2026 | 310.70M |
| August 07, 2026 | 311.66M |
| August 06, 2026 | 304.01M |
| August 05, 2026 | 301.14M |
| August 04, 2026 | 303.05M |
| August 03, 2026 | 288.71M |
| July 31, 2026 | 273.42M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Natera, Inc. | 57.55B |
| Sera Prognostics, Inc. | 80.45M |
| BioRestorative Therapies, Inc. | 2.433M |
| CareDx, Inc. | 3.278B |
| Exagen, Inc. | 203.71M |
Market Cap Related Metrics
| PS Ratio | 0.5008 |
| Price to Book Value | 1.356 |
| Price | 4.31 |
| Earnings Yield | -27.81% |